These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 2111050

  • 1. A plasma clot lysis assay based on the release of fibrin degradation products: application to the diagnosis of hypofibrinolytic states.
    Gaussem P, Gandrille S, Molho-Sabatier P, Capron L, Fiessinger JN, Aiach M.
    Thromb Haemost; 1990 Feb 19; 63(1):76-81. PubMed ID: 2111050
    [Abstract] [Full Text] [Related]

  • 2. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis.
    Declerck PJ, Mombaerts P, Holvoet P, De Mol M, Collen D.
    Thromb Haemost; 1987 Dec 18; 58(4):1024-9. PubMed ID: 3127914
    [Abstract] [Full Text] [Related]

  • 3. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B, Gluszko P, Undas A.
    Thromb Res; 2010 Jul 18; 126(1):e11-6. PubMed ID: 20471669
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clot lysis mediated by cultured human microvascular endothelial cells.
    Speiser W, Anders E, Binder BR, Müller-Berghaus G.
    Thromb Haemost; 1988 Dec 22; 60(3):463-7. PubMed ID: 3149047
    [Abstract] [Full Text] [Related]

  • 6. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF.
    J Lab Clin Med; 1993 Nov 22; 122(5):606-15. PubMed ID: 8228580
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 22; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 9. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F.
    Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812
    [Abstract] [Full Text] [Related]

  • 10. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D.
    Thromb Haemost; 1987 Feb 03; 57(1):67-72. PubMed ID: 3109059
    [Abstract] [Full Text] [Related]

  • 11. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay.
    Anglés-Cano E, Boutière B, Arnoux D, Masson C, Contant G, Benchimol P, Sampol J.
    Thromb Haemost; 1987 Oct 28; 58(3):843-9. PubMed ID: 3124285
    [Abstract] [Full Text] [Related]

  • 12. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.
    Leaker MT, Brooker LA, Mitchell LG, Weitz JI, Superina R, Andrew ME.
    Transplantation; 1995 Jul 27; 60(2):144-7. PubMed ID: 7624956
    [Abstract] [Full Text] [Related]

  • 13. Fibrinolysis and spinal injury. Relationship to post-traumatic deep vein thrombosis.
    Petäjä J, Myllynen P, Rokkanen P, Nokelainen M.
    Acta Chir Scand; 1989 Jul 27; 155(4-5):241-6. PubMed ID: 2508383
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun 27; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 15. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
    Lu H, Bruckert J, Soria J, Li H, de Gennes JL, Legrand A, Peynet J, Soria C.
    Blood Coagul Fibrinolysis; 1990 Oct 27; 1(4-5):513-6. PubMed ID: 1966796
    [Abstract] [Full Text] [Related]

  • 16. D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness.
    Speiser W, Mallek R, Koppensteiner R, Stümpflen A, Kapiotis S, Minar E, Ehringer H, Lechner K.
    Thromb Haemost; 1990 Oct 22; 64(2):196-201. PubMed ID: 2125371
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish LK, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan NP, Kozol RA.
    J Surg Res; 1998 Jan 22; 74(1):96-101. PubMed ID: 9536981
    [Abstract] [Full Text] [Related]

  • 19. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV, Barrertt-Bergshoeff M, Hekkenberg RT, Rijken DC.
    Thromb Haemost; 1999 Apr 22; 81(4):605-12. PubMed ID: 10235448
    [Abstract] [Full Text] [Related]

  • 20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.